Transition Therapeutics Inc Stock

Stocks

16-08-25	Transition Therapeutics : Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.	PR
16-06-03	Transition Therapeutics : Receives Notification From NASDAQ	PR
16-05-11	Transition Therapeutics : Announces Third Quarter Fiscal 2016 Financial Results	PR
16-05-09	Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST	PR
16-04-18	Transition Therapeutics : Provides Update on Type 2 Diabetes Drug Candidate TT401	PR

1 day

+0.52%

Manager	Title	Age	Since
Antonio F. Cruz CEO	Chief Executive Officer	73	1998-07-05

Director	Title	Age	Since
Antonio F. Cruz CHM	Chairman	73	2010-08-03

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
TRANSITION THERAPEUTICS INC	+0.52%	-6.31%	-	-	0
MODERNA, INC.	-0.74%	+14.21%	+679.75%	+96.98%	79.4B
REGENERON PHARMACEUTICALS, INC.	-4.61%	-5.11%	+35.07%	-9.24%	78.69B
CSL LIMITED	+2.80%	+3.60%	-6.34%	-27.82%	59.52B
UCB	-0.89%	+0.19%	-6.63%	+172.79%	46.58B
SAMSUNG BIOLOGICS CO.,LTD.	+2.49%	+0.14%	-8.95%	+33.71%	46.53B
BIOGEN INC.	+0.69%	+5.17%	+66.32%	-10.64%	33.63B
INCYTE CORPORATION	+0.08%	-0.07%	+48.48%	+112.52%	25.11B
INNOVENT BIOLOGICS, INC.	-3.56%	-0.47%	+3.11%	+135.37%	22.13B
SWEDISH ORPHAN BIOVITRUM AB	+0.73%	-0.95%	+57.27%	+97.04%	15.31B
Average	-0.23%	+4.30%	+96.45%	+66.74%	45.21B
Weighted average by Cap.	-0.52%	+6.71%	+147.51%	+53.78%